Coagulation profile of COVID-19 patients admitted to the ICU: An exploratory studyICU에 입원한 COVID-19 환자의 응고 프로파일: 탐색적 연구Research Article Published on 2020-12-152022-08-13 Journal: PLoS ONE [Category] Biochemistry, MERS, SARS, 치료기술, [키워드] abnormality addressed alteration anticoagulation Antithrombin aPTT baseline both groups change characterized Coagulation coagulation tests complex Conventional COVID-19 patient D-dimer Day decrease exploratory study fibrinogen Fibrinogen levels fibrinolysis fibrinolytic groups hypercoagulability ICU in both group in both groups INR Laboratory test Laboratory tests less Longitudinal evaluation magnitude median objective organ dysfunction Patient plasma plasminogen Platelet Protein protein C protein S remained Result severity slight increase SOFA SOFA score study period two groups were measured with COVID-19 [DOI] 10.1371/journal.pone.0243604 PMC 바로가기 [Article Type] Research Article
Hypercoagulopathy in Severe COVID-19: Implications for Acute Care중증 COVID-19에서의 과응고병증: 급성 치료에 대한 시사점Review Published on 2020-12-012022-09-11 Journal: Thrombosis and haemostasis [Category] MERS, SARS, 바이오마커, [키워드] affecting Care Coagulopathy Complication contribute COVID-19 described Diagnosis emergency department event hypercoagulability hypoxia immunothrombosis intensive care Occurrence pandemic pathological mechanism patients proportion pulmonary thrombosis therapeutic Thromboprophylaxis thrombosis Treatment venous thromboembolic Venous Thromboembolism [DOI] 10.1055/s-0040-1721487 PMC 바로가기 [Article Type] Review
Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine혈관 질환 또는 심혈관 위험 인자 및 COVID-19가 있는 환자의 관리를 위한 지침: VAS-European Independent Foundation in Angiology/Vascular Medicine의 입장 보고서Review Published on 2020-12-012022-09-12 Journal: Thrombosis and haemostasis [Category] MERS, SARS, 진단, [키워드] advanced age Antithrombotic Antiviral Arterial hypertension cardiovascular cardiovascular disease cardiovascular risk factor Care Community COVID-19 D-dimer Diabetes Mellitus disease disease symptoms eHealth technology Epidemic Factor Follow-up foundation Health high risk hospital discharge Hospitalization hospitalized patient hypercoagulability intermediate dose intravascular coagulation LMWH Male sex management manifested Medicine obesity oral anticoagulant paper Patient physical position progression receive risk risk factor severe COVID-19 Social distancing measure Thromboprophylaxis thrombosis Treatment treatment for COVID-19 unfractionated heparin Vascular vascular disease Venous Thromboembolism VTE VTE risk worsening [DOI] 10.1055/s-0040-1715798 PMC 바로가기 [Article Type] Review
Large Vessel Occlusion Secondary to COVID-19 Hypercoagulability in a Young Patient: A Case Report and Literature Review젊은 환자의 COVID-19 과응고성에 따른 대혈관 폐색: 증례 보고 및 문헌 검토Review Published on 2020-12-012022-09-11 Journal: Journal of stroke and cerebrovascular diseases : t [Category] 바이오마커, [키워드] abnormality acute respiratory syndrome acute respiratory syndrome coronavirus Admission affected African American aortic arch Atrial fibrillation average cardiac thrombus cardiac tumor Cardiomyopathy carotid carotid artery Cerebral artery clinically Coagulopathy complications Coronavirus-2 correlation COVID-19 COVID-19 infection cubic D-dimer D-dimer level disease Dissection edema elevated Evidence evidence of fibrinogen Final Foramen ovale highlight Hospitalization hypercoagulability hypercoagulable Hypercoagulable state IgM increasingly Infarction Infection internal carotid artery Large vessel occlusion literature marker Mechanical middle cerebral artery no evidence of normal values Occlusion on admission outcome Patent foramen ovale Patient patients with COVID-19 proximal pulmonary symptoms reached recognizing reperfusion report respiratory resulting review SARS-CoV-2 secondary to Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 stenosis stroke thromboembolic to define valvular Vascular vessel with COVID-19 Young patient. [DOI] 10.1016/j.jstrokecerebrovasdis.2020.105307 PMC 바로가기 [Article Type] Review
COVID-19 and Hypercoagulability: Potential Impact on Management with Oral Contraceptives, Estrogen Therapy and PregnancyArticle Published on 2020-12-012023-07-13 Journal: Endocrinology [Category] SARS, [키워드] coronavirus COVID-19 estrogen therapy hypercoagulability oral contraceptives Pregnancy [DOI] 10.1210/endocr/bqaa121 PMC 바로가기
COVID-19 versus HIT hypercoagulabilityCOVID-19 대 HIT 과응고성Review Published on 2020-12-012022-09-12 Journal: Thrombosis research [Category] MERS, SARS, 진단, [키워드] abnormality Admission Anticoagulant available data COVID-19 COVID-19 patients death deep-vein thrombosis Disseminated intravascular coagulation distress elevated fatal COVID-19 Frequency greater hematologic heparin heparin-induced thrombocytopenia hospital hypercoagulability increased risk initial intensive care limb lymphopenia Mild Myocardial infarction observational studies Occurrence Patient patient population Perspective Prognosis progression Prothrombin time recommendation reported required respiratory complication severe respiratory illness stroke syndrome thrombocytopenia Thromboprophylaxis thrombosis thrombotic event treating COVID-19 Treatment venous von Willebrand factor [DOI] 10.1016/j.thromres.2020.08.017 PMC 바로가기 [Article Type] Review
Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort studyResearch Article Published on 2020-11-162022-10-28 Journal: BMC Nephrology [Category] COVID-19, SARS, [키워드] Abstract Acute kidney injury Administered administration AKI anticoagulation Care citrate cohort study collected data coronavirus disease Course COVID-19 COVID-19 patient Critical care Critically ill Critically ill patient dialysis effective Efficiency Emerging communicable diseases event Germany Health Hemodialysis high risk hypercoagulability intensive care unit LMWH low molecular weight maintain outcome Patient patients Prevent receiving reduce regimen renal replacement therapy Result RRT Safe SARS-CoV-2 significantly supplementary material sustained systemic anticoagulation the disease therapeutic Thromboembolic events Treatment unfractionated heparin was performed [DOI] 10.1186/s12882-020-02150-8 PMC 바로가기 [Article Type] Research Article
COVID ‐19, thromboembolic risk, and Virchow’s triad: Lesson from the pastReview Published on 2020-11-112022-10-31 Journal: Clinical Cardiology [Category] COVID-19, MERS, [키워드] Acute myocardial infarction acute pulmonary embolism Blood blood stasis COVID COVID‐19 COVID‐19 patients COVID‐19 described diagnostic drug element endothelial injury Evidence explain Factor feature highlight hypercoagulability hypercoagulable immune system Infection lesson manifestation outlined placental thrombosis Pneumonia Respiratory disease SARS‐CoV‐2 stroke Symptom systemic arterial embolism thromboembolic thromboembolic risk Thromboembolism thrombosis Treatment unique variety venous [DOI] 10.1002/clc.23460 PMC 바로가기 [Article Type] Review
Biomarkers of Hypercoagulability and Endothelial Cell Activation in Patients with Severe COVID-19 Admitted at the Intensive Care Unit. the Roadmap-COVID-19 Prospective Observational StudyConference abstract Published on 2020-11-042022-10-05 Journal: Blood [Category] 바이오마커, [키워드] Activation acute respiratory distress acute respiratory syndrome Algorithm Antithrombotic AP-HP ARDS Biomarker Blood coagulation calculated cause cellular change characterized clinically clotting factor Cluster Coagulation cohort study complications consecutive patient Control control group controls coronavirus coronavirus disease COVID-19 D-dimer decrease disease download effect of treatment endothelial Endothelial cell Endothelial dysfunction enrolled evaluate evaluated excessive inflammation expressing fibrinogen FVIII healthy individual Heparanase Hospitalized hypercoagulability ICU ICU admission ICU patient IL-6 IL-6 level increase indicate indicated inflammatory reaction Inhaled inhibitor intensive care unit intrinsic life-threatening LMWH management mandatory Microparticle moderate modify molecular weight monomer MRI Multisystem organ failure outcome Paris pathway Patient patients patients hospitalized patients with COVID-19 peak platelet activation Pneumonia Prospective Prospective Study Protein protein S ranged Ratio Respiratory failure Result SARS-CoV-2 SARS-COV-2 infection severe COVID-19 shown significant decrease significantly STABLE syndrome table TFPI the mean the patient thrombin Thromboprophylaxis university von Willebrand factor were assessed with COVID-19 [DOI] 10.1182/blood-2020-140275 [Article Type] Conference abstract
Coronavirus-Associated Coagulopathy: Lessons From SARS-CoV1 and MERS-CoV for the Current SARS-CoV2 PandemicInternal Medicine Published on 2020-11-032022-10-31 Journal: Cureus [Category] COVID-19, [키워드] acute respiratory syndrome appear assist chest imaging clinical condition Clinical course clinician Coagulopathies Consensus Conservative management coronavirus coronavirus disease COVID-19 COVID-19-associated coagulopathy current Cytokine storm discharged home Effects elevated endothelial evaluate female Fever form Hospital stay hypercoagulability Hypothyroidism incidence Inflammation Inflammatory marker initial initiated intra-alveolar intubation left upper lobe lesson low molecular weight main pulmonary artery management manuscript mechanical ventilation MERS-CoV Middle East multifactorial nasopharyngeal nonproductive cough Pathogenesis pathophysiology Patient patients PCR test pro-inflammatory state Prophylactic recommendation remained respiratory syndrome coronavirus risk SARS virus SARS-CoV2 SARS-CoV2 infection SARS-CoV2- Seven stroke suggested systemic anticoagulation the timing therapeutic anticoagulation thrombosis Thrombotic complications tomography transferred while worsened [DOI] 10.7759/cureus.11310 PMC 바로가기 [Article Type] Internal Medicine